N/A
Completed N=83
Creative Arts Therapy (CAT) in the Center for Cancer and Blood Disorders
Source: ClinicalTrials.gov NCT04208243 ↗Enrolled (actual)
83
Serious AEs
0.0%
Results posted
Jun 2022
Primary outcomePrimary: PedsQL 3.0 Cancer Module Scale — 71.59 score on a scale
Summary
The purpose of the study is to evaluate the effectiveness of Creative Arts Therapy (CAT) on pediatric patients undergoing chemotherapy in the Infusion Center at Children's Hospital Colorado Center for Cancer and Blood Disorders. Findings from a previous pilot study support the hypothesis that CAT may improve quality of life (QOL), resiliency, physical posture, and emotional response to pain of pediatric oncology patients undergoing chemotherapy.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY PedsQL 3.0 Cancer Module Scale |
71.59 | — |
| PRIMARY The Resilience Scale (RS) |
82.86 | — |
| PRIMARY McGrath Faces Scale |
2.89 | — |
| PRIMARY Postural Measurement by Inclinometer |
25.47 | — |
Eligibility Criteria
Inclusion Criteria
- Center for Cancer and Blood Disorders (CCBD) patient with Oncology or Neuro-oncology diagnosis
- No more than 2 previous sessions of CAT as an outpatient in the CCBD
- English speaking
- Receiving outpatient chemotherapy, biotherapy, or transfusions in the infusion center approximately weekly for at least 3 months.
- Ages 3 to 18 years
Exclusion Criteria
- Hematology or other patients in the infusion center
- Patients who have previously received more than 2 sessions of CAT in the infusion center
- Non-English speaking patients
Data sourced from ClinicalTrials.gov (NCT04208243). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.